Related Experiment Videos
Synchronous multifocal bone sarcomas--a case report and molecular pathologic investigation
H Walter1, R Schneider-Stock, W Mellin
1Department of Pathology, Otto von Guericke University Magdeburg, Germany.
General & Diagnostic Pathology
|May 1, 1995
Summary
This case study details a woman with two distinct malignant bone tumors: dedifferentiated chondrosarcoma and malignant fibrous histiocytoma (MFH). Molecular analysis suggests they are separate primary tumors, not a metastasis.
Area of Science:
- Orthopedic Oncology
- Skeletal Pathology
- Molecular Diagnostics
Background:
- Synchronous occurrence of distinct malignant bone tumors is rare.
- Differentiating between primary bone tumors and metastases is crucial for treatment.
Observation:
- A 54-year-old woman presented with synchronous dedifferentiated chondrosarcoma (olecranon) and malignant fibrous histiocytoma (MFH) (tibia).
- The chondrosarcoma's anaplastic component resembled MFH, while the tibial MFH showed a storiform-pleomorphic pattern.
- Immunohistochemistry, DNA-cytometry, and p53 gene analysis were performed on both tumors.
Findings:
- Dedifferentiated chondrosarcoma exhibited an aneuploid stem cell line and a p53 gene mutation (exon-8).
- The tibial MFH lacked aneuploid stem cells and the specific p53 mutation.
- Myogenous differentiation markers were positive in the tibial MFH but absent in the chondrosarcoma's anaplastic cells.
Implications:
- The distinct genetic profiles and cellular characteristics support the conclusion that the tibial MFH is a separate primary malignancy.
- This case highlights the importance of comprehensive molecular and histological analysis in diagnosing synchronous bone tumors.
- Accurate diagnosis is essential for appropriate therapeutic strategies in patients with multiple bone malignancies.